前往化源商城

American Journal of Physiology: Renal, Fluid & Electrolyte Physiology (Abstracts) 2015-07-15

Pleiotropic signaling evoked by tumor necrosis factor in podocytes.

Mousa Abkhezr, Eun Young Kim, Hila Roshanravan, Fotis Nikolos, Christoforos Thomas, Henning Hagmann, Thomas Benzing, Stuart E Dryer

文献索引:Am. J. Physiol. Renal Physiol. 309 , F98-108, (2015)

全文:HTML全文

摘要

TNF has been implicated in glomerular diseases, but its actions on podocytes are not well understood. Endogenous TNF expression is markedly increased in mouse podocytes exposed to sera from patients with recurrent focal segmental glomerulosclerosis, and TNF is able to increase its own expression in these cells. Exposure of podocytes to TNF increased phosphorylation of NF-κB p65-RelA followed by increased tyrosine phosphorylation of STAT3. STAT3 activation was blocked by the NF-κB inhibitor JSH-23 and by the STAT3 inhibitor stattic, whereas TNF-evoked NF-κB activation was not affected by stattic. TNF treatment increased nuclear accumulation of nuclear factor of activated T cells (NFAT)c1 in podocytes, a process that occurred downstream of STAT3 activation. TNF also increased expression of cyclin D1 but had no effect on cyclin-dependent kinase 4, p27(kip), or podocin. Despite its effects on cyclin D1, TNF treatment for up to 72 h did not cause podocytes to reenter the cell cycle. TNF increased total expression of transient receptor potential (TRP)C6 channels through a pathway dependent on NFATc1 and increased the steady-state expression of TRPC6 subunits on the podocyte cell surface. TNF effects on TRPC6 trafficking required ROS. Consistent with this, La(3+)-sensitive cationic currents activated by a diacylglycerol analog were increased in TNF-treated cells. The effects of TNF on NFATc1 and TRPC6 expression were blocked by cyclosporine A but were not blocked by the pan-TRP inhibitor SKF-96365. TNF therefore influences multiple pathways previously implicated in podocyte pathophysiology and is likely to sensitize these cells to other insults. Copyright © 2015 the American Physiological Society.

相关化合物

结构式 名称/CAS号 全部文献
1-[2-(4-甲氧基)-2-[3-(4-甲氧基苯基)丙氧基]乙基]咪唑 结构式 1-[2-(4-甲氧基)-2-[3-(4-甲氧基苯基)丙氧基]乙基]咪唑
CAS:130495-35-1
1-油酰基-2-乙酰基-sn-丙三醇 结构式 1-油酰基-2-乙酰基-sn-丙三醇
CAS:86390-77-4
碘化丙啶 结构式 碘化丙啶
CAS:25535-16-4
4-(3-膦酰基丙基)哌嗪-2-羧酸 结构式 4-(3-膦酰基丙基)哌嗪-2-羧酸
CAS:100828-16-8
乙二胺四乙酸 结构式 乙二胺四乙酸
CAS:60-00-4